Baxter International Inc. vs. LeMaitre Vascular, Inc.
Baxter International Inc. (BAX) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| BAX | LMAT | |
|---|---|---|
| Market Cap | $14.24 billion | $1.86 billion |
| Revenue (TTM) | $11.47 billion | $262.43 million |
| Net Income (TTM) | $-1,063,000,000 | $65.67 million |
BAX leads on 2 of 3 size & scale factors.
Valuation
| BAX | LMAT | |
|---|---|---|
| P/E Ratio | — | 28.58 |
| Price / Book | 2.31 | 4.43 |
| Price / Sales | 1.24 | 7.10 |
BAX leads on 2 of 2 valuation factors.
Profitability
| BAX | LMAT | |
|---|---|---|
| Net Margin | -9.27% | 25.02% |
| Return on Equity | -17.20% | 15.62% |
LMAT leads on 2 of 2 profitability factors.
Dividend
| BAX | LMAT | |
|---|---|---|
| Dividend Yield | — | 1.23% |
| Payout Ratio | — | 35.09 |
BAX and LMAT split the dividend factors evenly.
Risk & Sentiment
| BAX | LMAT | |
|---|---|---|
| Short Interest | 1.03% | 4.36% |
BAX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BAX overview, BAX financials, LMAT overview, LMAT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.